BAX
Baxter International Inc
NYSE: BAX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$17.53
-2.56% today
Updated 2026-05-11
Market cap
$9.05B
P/E ratio
—
P/S ratio
0.80x
EPS (TTM)
$-1.91
Dividend yield
2.00%
52W range
$16 – $32
Volume
8.6M
Baxter International Inc (BAX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-9.70%
Operating margin
6.03%
ROE
-15.00%
ROA
2.85%
Debt/equity
1.60x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $10.38B | $1.40B | 45.64% | 17.74% | 13.45% |
| 2007 | $11.26B | $1.71B | 49.00% | 19.25% | 15.16% |
| 2008 | $12.35B | $2.01B | 49.64% | 20.76% | 16.31% |
| 2009 | $12.56B | $2.21B | 51.94% | 22.90% | 17.55% |
| 2010 | $12.84B | $1.42B | 46.39% | 16.63% | 11.06% |
| 2011 | $13.89B | $2.22B | 50.72% | 21.20% | 16.01% |
| 2012 | $13.94B | $2.33B | 51.19% | 20.24% | 16.69% |
| 2013 | $9.41B | $2.01B | 44.22% | 5.27% | 21.37% |
| 2014 | $10.72B | $2.50B | 42.74% | 6.12% | 23.30% |
| 2015 | $9.97B | $968.00M | 41.59% | 4.50% | 9.71% |
| 2016 | $10.16B | $4.96B | 40.50% | 7.33% | 48.85% |
| 2017 | $10.58B | $602.00M | 42.27% | 12.17% | 5.69% |
| 2018 | $11.10B | $1.55B | 42.88% | 14.27% | 13.93% |
| 2019 | $11.36B | $1.00B | 41.90% | 15.60% | 8.81% |
| 2020 | $11.67B | $1.10B | 39.30% | 13.84% | 9.44% |
| 2021 | $12.15B | $1.28B | 38.86% | 11.11% | 10.57% |
| 2022 | $10.06B | $-2.43B | 35.29% | -28.29% | -24.19% |
| 2023 | $10.36B | $2.66B | 40.06% | 6.82% | 25.64% |
| 2024 | $10.64B | $-649.00M | 37.46% | 0.13% | -6.10% |
| 2025 | $11.24B | $-957.00M | 30.05% | -2.74% | -8.51% |